TrialBritish journal of cancer2006

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy.

J Hannemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.